SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-21-036441
Filing Date
2021-07-13
Accepted
2021-07-13 16:09:36
Documents
80
Period of Report
2021-04-30

Document Format Files

Seq Description Document Type Size
1 10-K kalv-10k_20210430.htm 10-K 2550672
2 EX-10.18 kalv-ex1018_356.htm EX-10.18 131858
3 EX-10.21 kalv-ex1021_555.htm EX-10.21 2118201
4 EX-23.1 kalv-ex231_9.htm EX-23.1 2176
5 EX-31.1 kalv-ex311_11.htm EX-31.1 58127
6 EX-31.2 kalv-ex312_12.htm EX-31.2 55731
7 EX-32.1 kalv-ex321_10.htm EX-32.1 16263
8 EX-32.2 kalv-ex322_6.htm EX-32.2 17351
9 GRAPHIC gk5g4onp2lz3000002.jpg GRAPHIC 3615
10 GRAPHIC gk5g4onp2lz3000006.jpg GRAPHIC 3615
11 GRAPHIC gptjcpbswis2000001.jpg GRAPHIC 227942
12 GRAPHIC gk5g4onp2lz3000003.jpg GRAPHIC 3615
13 GRAPHIC gk5g4onp2lz3000001.jpg GRAPHIC 3615
14 GRAPHIC gk5g4onp2lz3000004.jpg GRAPHIC 3615
15 GRAPHIC gk5g4onp2lz3000005.jpg GRAPHIC 3615
  Complete submission text file 0001564590-21-036441.txt   9962941

Data Files

Seq Description Document Type Size
16 XBRL INSTANCE DOCUMENT kalv-20210430.xml EX-101.INS 1362749
17 XBRL TAXONOMY EXTENSION SCHEMA kalv-20210430.xsd EX-101.SCH 48775
18 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kalv-20210430_cal.xml EX-101.CAL 59620
19 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kalv-20210430_def.xml EX-101.DEF 121359
20 XBRL TAXONOMY EXTENSION LABEL LINKBASE kalv-20210430_lab.xml EX-101.LAB 407506
21 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kalv-20210430_pre.xml EX-101.PRE 291449
Mailing Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Filer) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-K | Act: 34 | File No.: 001-36830 | Film No.: 211087997
SIC: 2834 Pharmaceutical Preparations